Commentary|Podcasts|November 18, 2025

Inside AHA’s Late-Breaking Lipid Trials: The Rise of Oral PCSK9 Inhibition

Fact checked by: Ron Panarotti

This week, host Craig Beavers spoke with Joe Saseen, PharmD, BCPS, BCACP, CLS, about several key trials presented at the American Heart Association 2025 Scientific Sessions.

Show notes:

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.


Latest CME